Novartis Pharmaceuticals Australia Pty Ltd - Notification - N98692

Date lodged: 
9 November 2015
Type: 
Exclusive dealing notification
Status: 
Completed
Outcome: 
Allowed to stand

Applicant(s)

  • Novartis Pharmaceuticals Australia Pty Ltd

Notification number(s)

  • N98692

Summary

Novartis will supply a range of services under its Pathway Program on condition that patients purchase Glivec of Tasigna prescribed by their treating physician through APG Cooleman Pty Ltd (APG).

Notifications

Document title Date
Received ( PDF 2.19 MB ) 9 Nov 2015

ACCC correspondence

Document title Date
ACCC to Applicant re No Further Action ( HTM 52.49 KB ) 7 Dec 2015